Improving health evaluations to capture wider value of therapeutics and incentivise innovation
Year: 2023
Type: article
Abstract: elements of value, insurance value, antimicrobial resistance, pandemics, value assessmentPrevention is better than cure-but how to value prevention and incentivise investment?
Source: Frontiers in Public Health
Institutions: Pfizer (United Kingdom), Imperial College London
Language: English
Subfield: Economics and Econometrics
Domain: Social Sciences
Open Access status: gold
Estimated APC paid: $3,295
Funder: Pfizer
OpenAlex ID: W4362467148
